BSE Live
Dec 04, 16:01Prev. Close
934.55
Open Price
937.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 04, 15:59Prev. Close
935.40
Open Price
939.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
949.25 (738)
| Cash Flow of Natco Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 2,291.40 | 1,673.50 | 861.90 | 202.20 | 579.60 | |
| Net CashFlow From Operating Activities | 1,696.80 | 1,211.60 | 849.10 | 46.50 | 298.80 | |
| Net Cash Used In Investing Activities | -1,414.50 | -1,032.70 | -477.10 | -5.30 | -103.30 | |
| Net Cash Used From Financing Activities | -210.70 | -246.90 | -363.00 | 34.80 | -185.70 | |
| Foreign Exchange Gains / Losses | -22.00 | 6.50 | 11.80 | 9.30 | -3.80 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 49.60 | -61.50 | 20.80 | 85.30 | 6.00 | |
| Cash And Cash Equivalents Begin of Year | 70.40 | 131.90 | 111.10 | 25.80 | 19.80 | |
| Cash And Cash Equivalents End Of Year | 120.00 | 70.40 | 131.90 | 111.10 | 25.80 |
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
24.11.2025
24.11.2025
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
14.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
09.09.2025
Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y